Interleukin-2, cisplatin, and 5-fluorouracil for patients with non-small cell lung and head/neck carcinomas.

Valone, F H

Interleukin-2, cisplatin, and 5-fluorouracil for patients with non-small cell lung and head/neck carcinomas. [electronic resource] - Journal of immunotherapy : official journal of the Society for Biological Therapy Jun 1991 - 207-13 p. digital

Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

1053-8550

10.1097/00002371-199106000-00007 doi


Adult
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Carcinoma, Non-Small-Cell Lung--drug therapy
Cisplatin--administration & dosage
Drug Administration Schedule
Drug Evaluation
Female
Fluorouracil--administration & dosage
Head and Neck Neoplasms--drug therapy
Humans
Interleukin-2--administration & dosage
Lung Neoplasms--drug therapy
Male
Middle Aged
Survival Rate